I agree that this site is using cookies. You can find further informations here.
X
Shitara, K.
137  results:
Search for persons X
?
1

Comparative efficacy of PD-1 blockade in patients with dMMR..:

Mazzoli, G. ; Nichetti, F. ; Shitara, K....
ESMO Gastrointestinal Oncology.  3 (2024)  - p. 100037 , 2024
Link: https://doi.org/10.1016/..
 
?
2

495TiP CLARITY-Gastric 01: A randomised phase III study of ..:

Shitara, K. ; Janjigian, Y.Y. ; Elimova, E....
Annals of Oncology.  35 (2024)  - p. S196-S197 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Corrigendum to "Comprehensive clinical and molecular charac..:

Kubota, Y. ; Kawazoe, A. ; Mishima, S....
ESMO Open.  9 (2024)  1 - p. 102232 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Safety and efficacy of perioperative FLOT regimen in Japane..:

Takei, S. ; Kawazoe, A. ; Jubashi, A....
ESMO Gastrointestinal Oncology.  4 (2024)  - p. 100050 , 2024
Link: https://doi.org/10.1016/..
 
?
5

267MO Pooled analysis of trastuzumab deruxtecan (T-DXd) ret..:

Rugo, H.S. ; Tokunaga, E. ; Iwata, H....
ESMO Open.  9 (2024)  - p. 103326 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Pan-Asian adapted ESMO Clinical Practice Guidelines for the..:

Shitara, K. ; Fleitas, T. ; Kawakami, H....
ESMO Open.  9 (2024)  2 - p. 102226 , 2024
Link: https://doi.org/10.1016/..
 
?
7

500TiP An open label phase Ib/II study of trastuzumab derux..:

Aoki, Y. ; Nakayama, I. ; Fukuoka, S....
Annals of Oncology.  35 (2024)  - p. S199 , 2024
Link: https://doi.org/10.1016/..
 
?
8

419P Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as fi..:

Wyrwicz, L.S. ; Shitara, K. ; Moehler, M....
Annals of Oncology.  35 (2024)  - p. S169-S170 , 2024
Link: https://doi.org/10.1016/..
 
?
9

LBA3 Final analysis of the phase III KEYNOTE-585 study of p..:

Shitara, K. ; Rha, S.Y. ; Wyrwicz, L.S....
Annals of Oncology.  35 (2024)  - p. S213 , 2024
Link: https://doi.org/10.1016/..
 
?
10

501TiP Valemetostat and trastuzumab deruxtecan (T-DXd) in p..:

Shitara, K. ; Enzinger, P.C. ; Mohapatra, A.S..
Annals of Oncology.  35 (2024)  - p. S200 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Association of PD-L1 and PD-L2 expression and tumor-infiltr..:

Imai, M. ; Nakamura, Y. ; Denda, T....
ESMO Gastrointestinal Oncology.  2 (2023)  - p. 100008 , 2023
Link: https://doi.org/10.1016/..
 
?
12

ARCAD-Asia initiative: leveraging yesterday's data for tomo..:

Takeda, Y. ; Misumi, T. ; Bando, H....
ESMO Gastrointestinal Oncology.  2 (2023)  - p. 100007 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Comprehensive clinical and molecular characterization of cl..:

Kubota, Y. ; Kawazoe, A. ; Mishima, S....
ESMO Open.  8 (2023)  1 - p. 100762 , 2023
Link: https://doi.org/10.1016/..
 
?
14

A phase II study to explore biomarkers for the use of mFOLF..:

Okamoto, W. ; Sakai, K. ; Makiyama, A....
ESMO Open.  7 (2022)  6 - p. 100592 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Pooled safety analysis from phase III studies of trifluridi..:

Van Cutsem, E. ; Hochster, H. ; Shitara, K....
ESMO Open.  7 (2022)  6 - p. 100633 , 2022
Link: https://doi.org/10.1016/..
 
1-15